Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
株式のランク #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
株価
$41.14
最終同期: 2026-09-21
時価総額
$182.76B
変化(1日)
-7.78%
変化(1年)
-32.24%
DK
取引 Novo Nordisk A/S (NOVO-B)

カテゴリー

Novo Nordisk A/S(NOVO-B)のP/S比率
September 2026 時点のP/S比率 TTM: 3.78
Novo Nordisk A/S の最新の財務報告および株価によると、現在のP/S比率(TTM)は 3.78 です。2024 年末時点でのP/S比率は 9.57 でした。
Novo Nordisk A/S の P/S 比率の履歴(2000 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 3.78 -19.20%
2025 4.68 -51.16%
2024 9.57 -28.95%
2023 13.47 12.21%
2022 12.01 0.14%
2021 11.99 52.88%
2020 7.84 4.26%
2019 7.52 14.27%
2018 6.58 -10.96%
2017 7.39 28.28%
2016 5.76 -39.48%
2015 9.53 23.95%
2014 7.69 20.58%
2013 6.37 -2.85%
2012 6.56 16.63%
2011 5.62 -6.38%
2010 6.01 54.26%
2009 3.89 6.22%
2008 3.67 -25.10%
2007 4.90 23.93%
2006 3.95 14.37%
2005 3.45 -0.13%
2004 3.46 11.99%
2003 3.09 9.60%
2002 2.82 -43.18%
2001 4.96 6.86%
2000 4.64 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
13.45 255.68%
US
6.55 73.32%
US
7.18 89.91%
US
4.66 23.19%
CH
5.39 42.48%
US